Galera Therapeutics, Inc.

GRTXOTCHealthcare● Active

$0.09

+$0.01(+8.24%)

Market Cap$6982143

P/E Ratio—

52W High$0.15

52W Low$0.015

Avg Volume298K

Open$0.09

Beta2.59

Overview

Galera Therapeutics, Inc. (GRTX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

GRTX · net income · updated Jun 15, 2026

Core profitability metrics

GRTX · net income · margin · TTM · CAGR

Net income was $149.0M for FY2025 (fiscal year ending 2025-12-31), up 886.2% year-over-year. Net profit margin was —. Based on available data, Galera Therapeutics, Inc. has been profitable since at least 2025.

FY2025 Net Income$149.0M▲ +886.2% YoY

Trailing 12M (TTM)$149.0Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+886.2%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 15, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2025

▸ FMP /income-statement · Annual · GRTX net income history · GRTX profit margin

Annual net income data

GRTX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025★ First Profit$149.0M▲ +886.2%—$0

FY2024Loss−$19.0M▲ +67.9%—$0

FY2023Loss−$59.1M▲ +5.0%—$0

FY2022Loss−$62.2M▲ +22.7%—$0

FY2021Loss−$80.5M▼ 8.5%—$0

Net income vs peers (Healthcare)

GRTX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Galera Therapeutics, Inc.YOU

GRTX

$149.0M+886.2%—

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Galera Therapeutics, Inc. (GRTX) reported net income of $149.0M for FY2025 (fiscal year ending 2025-12-31), up 886.2% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Galera Therapeutics, Inc. has been profitable since at least 2025. Net income reached a peak of $149.0M in FY2025. Data available for 9 fiscal years.

Galera Therapeutics, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Galera Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from GRTX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

GRTX net income · 5 questions

Galera Therapeutics, Inc. is profitable. The company reported net income of $149.0M for FY2025, a net profit margin of —. Net income was up 886.2% year-over-year. Based on available data, Galera Therapeutics, Inc. has been profitable since at least 2025.

is GRTX profitabledoes GRTX make a profitGRTX profitabilityGRTX profitable company

▸ Source: FMP /income-statement · GAAP · Galera Therapeutics, Inc. · Galera Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026